The Last Mile of Pharma: What Actually Changes HCP Behavior
About this Meeting
AI is beginning to reshape how pharmaceutical companies engage healthcare professionals across commercial and medical functions. From content generation and personalization to field force enablement and next-best-action strategies, organizations are exploring how AI can support more targeted, timely, and relevant interactions with HCPs.
At the same time, many pharma teams are working through how to integrate these capabilities into highly regulated environments while balancing efficiency, compliance, and trust. Questions are emerging around what level of personalization is genuinely valuable, how AI-generated content should be governed, and whether these approaches are meaningfully influencing HCP engagement and prescribing behavior in practice.
This roundtable brings together leaders across pharma commercial operations, medical affairs, digital engagement, and AI strategy to explore how organizations are operationalizing AI across the last mile of HCP engagement. The discussion will focus on where teams are seeing measurable impact, how workflows are evolving, and what it takes to scale these approaches responsibly across large organizations.
Join us to discuss:
How are pharma organizations using AI to personalize HCP engagement and support commercial and medical teams?
What operational, compliance, and governance challenges are emerging as AI-generated content becomes more widespread?
Where are organizations seeing measurable impact on engagement, field force effectiveness, and prescribing behavior?